I speak in favor of the proposed regulatory change.
PAs are medical professionals with a DEA license allowing prescriptive authority for Schedule II-V medications. They follow standards of care and prescribe medications as indicated. The current regulation implies PAs require oversight for prescribing controlled medications. Our NP colleagues do not require this oversight, and PAs should also not require such oversight for prescriptions.